Ledger.Open graph →
SEC Form D · filed March 25, 2019

Elysium Therapeutics, Inc

Offering
$1.5M
Sold
$215K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
DANVILLE, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Kathy E. Laporte · Danville, CADirectorThomas E. Jenkins · Danville, CAExec · DirectorAlex G. Sturmer · Danville, CAExec · DirectorBob E. Rappaport · Danville, CADirectorTommaso Furlanello · Bellevue, WADirectorAneesh Sachdeva · Bellevue, WAExec · DirectorAetos Capital Partners Management, LLC · New York, NYDirectorAetos Capital Partners GP, LLC · New York, NYExec · DirectorMartin Edwards · Boston, MADirectorMorgan Creek Capital Management, LLC · Chapel Hill, NCExec · DirectorMichael B. Watts · Laguna Hills, CADirectorBryan O'Rear · Ann Arbor, MIExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗